![These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. Approval: 2014 These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. Approval: 2014](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=otezla-06.jpg&id=730694)
These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. Approval: 2014
![These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. approval: 2014 These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. approval: 2014](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=otezla-06.jpg&id=544787)
These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral use Initial U.S. approval: 2014
![Otezla, el medicamento antiinflamatorio oral adquirido por Amgen, está aprobado para la tercera indicación en la UE! - Conocimiento - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Otezla, el medicamento antiinflamatorio oral adquirido por Amgen, está aprobado para la tercera indicación en la UE! - Conocimiento - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](http://www.hspchem.com/Content/uploads/2020524038/202005210954501fb06720a06142bc887aeffb62f851d4.png)